What you'll hear
- How has COVID-19 impacted clinical trials?
- What barriers still exist?
- What do investigators, patients, and industry need in order to continue making progress in trials?
- Have investigators seen an increase in the diversity of participants?
- How quickly and successfully has industry pivoted to decentralized/hybrid design trials?
